This Week in Nature

In Nature, a group from Massachusetts General Hospital presented details about new, high-fidelity CRISPR/Cas9 nuclease that enable targeted genome editing with no apparent off-target effects. The nuclease is designed to carry alterations that reduce non-specific DNA contacts, and when targeted to standard non-repetitive sequences, it rendered nearly all off-target events undetectable by genome-wide break capture and targeted sequencing methods.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.